Therapeutic Targeting of PI3K and CDK9 in AML

Thomas, D; Powell, J; Vergez, F; Barry, EF; Sarry, JE; Truong, N; Manenti, S; Recher, C; Wei, AH; Guthridge, Mark

Therapeutic Targeting of PI3K and CDK9 in AML

conference contribution

posted on 2024-06-05, 04:18 authored by D Thomas, J Powell, F Vergez, EF Barry, JE Sarry, N Truong, S Manenti, C Recher, AH Wei, Mark GuthridgeMark Guthridge

Therapeutic Targeting of PI3K and CDK9 in AML

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1007/s00277-012-1669-x

Location

Munich, Germany

Language

English

Author URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344939100041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Volume

92

Pagination

S17-S17

Start date

2013-02-24

End date

2013-02-27

ISSN

0939-5555

eISSN

1432-0584

Title of proceedings

Annals of Hematology

Event

ACUTE LEUKEMIAS XIV- Biology and Treatment Strategies

Publisher

Springer

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Hematology

Therapeutic Targeting of PI3K and CDK9 in AML

History

Related Materials

Location

Language

Author URL

Publication classification

Volume

Pagination

Start date

End date

ISSN

eISSN

Title of proceedings

Event

Publisher

Usage metrics

Categories

Keywords

Licence

Exports